Posts filed under: Peripheral Vascular

The PMA covers the treatment of atherosclerotic lesions in common and external iliac arteries with diameters of 4.5mm to 12.0mm and lesion lengths of up to 100mm, Murray Hill, N.J.-based Bard said....
Continue Reading →
Contego Medical, LLC recently announced that it has received CE Marking of its Vanguard IEP™ Peripheral Balloon Angioplasty System with Integrated Embolic Protection. ...
Continue Reading →
FDA approval of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis marks the availability of the only balloon expandable stent graft with an indication for the iliac artery. ...
Continue Reading →
Register to receive a free US Peripheral Vascular Device Market – 2016 report synopsis and brochure W.L. Gore recently announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a fluoropolymer...
Continue Reading →
The European peripheral vascular device market value is expected to reach over €1.4 billion by 2022. The strong growth in this market is a result of the increase in usage of radiolabeled and drug-eluting beads....
Continue Reading →
The U.S. power-injectable implantable port market is expected to increase over the forecast period, driven predominantly by cancer treatments that require long-term vascular access....
Continue Reading →
Growth in the value of the covered stent segment in the U.S. peripheral vascular stent market will outpace growth in the value of the bare-metal stent segment over the forecast period....
Continue Reading →
Teleflex recently announced that the FDA has labeled the global recall of more than 47,000 Arrow International intra-aortic balloon catheter kits and percutaneous insertion kits as a Class I corrective action....
Continue Reading →
Positive clinical data, the development of new technology and the recent FDA approval of two drug coated balloons are increasing atherectomy procedural volume and driving growth in the demand for atherectomy devices...
Continue Reading →
By Kamran Zamanian, Ph.D, and Sean Collins, iData Research Inc. Growth of the United States’ elderly population has driven a steady increase in the number of patients requiring treatment for peripheral vascular lesions. Meanwhile, the availability of increasingly sophisticated technology...
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

Already have an account? Sign in

×